India's Bioeconomy Hits $195.3B, Aims for $300B by 2030

India's bioeconomy grew 18% to $195.3 billion in 2025, targeting $300 billion by 2030 via Biofoundry Network and BioE3 policy.
The Biopharma SHAKTI scheme allocates ₹10,000 crore over five years to boost domestic biopharma and reduce import dependence.
The BIG programme has supported 1,000+ startups, filed 800+ IPs, and generated 3,500+ jobs, mobilizing ₹3,500 crore in follow-on funding.